Ardent Health Partners Inc. (ARDT) Insider Trading

Last 12 months

Insiders bought $186k on the open market and sold nothing.

Net open-market

+$186k

2 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

2 / 0

executives and directors

Last open-market buy

Jun 2026

Jun 5, 2026

Get an email when ARDT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 5	Robert Demichiei Director	Bought	11,260	$8.73	$98k	46%	Form 4
Jun 5	Alfred Lumsdaine Chief Financial Officer	Bought	10,000	$8.81	$88k	3.1%	Form 4
Nov 8, 2024	Robert Thomas Webb Director	Bought 2 parts	20,000	$16.98 average	$340k	99%	Form 4

Jun 5
Robert Demichiei
Director · bought 11,260 at $8.73
$98k
46% of stake
Jun 5
Alfred Lumsdaine
Chief Financial Officer · bought 10,000 at $8.81
$88k
3.1% of stake
Nov 8, 2024
Robert Thomas Webb
Director · bought 20,000 at avg $16.98
$340k
99% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ARDT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-General Medical & Surgical Hospitals, NEC

SGRYSurgery Partners Inc.

CYHCommunity Health Systems, Inc.

UHSUniversal Health Services, Inc.

THCTenet Healthcare Corporation

EHCEncompass Health Corporation

SEMSelect Medical Holdings Corp.

MDPediatrix Medical Group, Inc.

AGLAgilon Health Inc.

Spot a number that looks wrong? Check it in ARDT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ARDT

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.